��������

Charmaine Gittleson serves as the Chair of the Board of Directors at Patrys Limited and Percheron Therapeutics Limited, with additional roles as a Non-Executive Director at George Health and the National Council of Jewish Women of Australia. With extensive experience in the healthcare biotechnology sector, Gittleson provides strategic insights to private equity investment companies and biotech organizations, highlighting a strong background in pharmaceutical medicine and executive leadership. Prior positions include Chief Medical Officer and SVP Clinical Development at CSL Behring, as well as various leadership roles at CSL Ltd., Covance, and Merck Sharp & Dohme South Africa. Gittleson holds a GAICD in Board Governance from the Australian Institute of Company Directors and degrees in BSc. MBBCh from the University of the Witwatersrand.